Health Trials

Cow Milk Protein Allergy

4

Review clinical trials related to Cow Milk Protein Allergy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Growth And Safety Outcomes In Infants With Cow´s Milk Protein Allergy (CMPA) Fed A Novel Extensively Hydrolyzed Formula (eHF)

Growth and safety Outcomes in infants with CMPA fed a novel extensively hydrolyzed formula.

Participants needed: 410
Trial details
Age: 29-22Biological sex: AllType: InterventionalSponsor: Société des Produits Nestlé (SPN)Updated: Jul 17, 2026
Eligibility criteria

Full-term infant(gestational age ≥37 weeks and ≤42 weeks). [+5]

Prior use of eHF, HRF or AAF for more than 2 weeks before randomization. [+14]

Read more
Status: Not yet recruiting

Partially Hydrolysed Whey Based Formula in Differentiation Between Non IgE Gastrointestinal Cow's Milk Protein Allergy and Milk Intolerance

Partially hydrolysed whey based formula in differentiation between non IgE gastrointestinal cow's milk protein allergy and milk intolerance

Participants needed: 100
Trial details
Age: 1-6Biological sex: AllType: InterventionalSponsor: Ain Shams UniversityUpdated: Jul 7, 2026Locations: 1
Eligibility criteria

1-6 months of age [+3]

IgE mediated disease [+3]

Read more
Status: Not yet recruiting

Tolerance and Growth Outcomes of an Extensively Hydrolysed Anti-regurgitation Casein-based Formula in Infants With Cow's Milk Protein Allergy

This study is designed as multicentric, interventional, with two successive randomised, double-blind, crossovers. The aim of the study is to demonstrate the tolerance of an extensively hydrolysed anti-regurgitation casein-based formula in infants with cow's milk protein allergy. After a confirmation of the diagnostic, this demonstration will be performed with oral food challenge. Secondarily, a long term tolerance phase will be performed to get growth outcomes with a consumption of the formula compared with a non-enriched formula.

Participants needed: 55
Trial details
Age: 1-9Biological sex: AllType: InterventionalSponsor: LactalisUpdated: May 26, 2026
Eligibility criteria

a suspicion of CMPA based on suggestive allergic symptoms [+6]

GI disease or abnormalities (i.e. short bowel syndrome, chronic intestinal disea... [+3]

Read more
Status: Recruiting

Effect of a Hydrolyzed Rice Protein-based Formula on Growth, Tolerance, and Health-related Quality of Life in Infants With Cow's Milk Protein Allergy.

The main purpose of this study is to demonstrate that the growth of infants fed with the Test Formula is non-inferior those fed with the Control Formula. The study will also evaluate the gastrointestinal tolerance, quatliy of life and acceptability of the new rice protein-based formula in infants with cow's milk protein allergy (CMPA).

Participants needed: 104
Trial details
Age: Up to 8Biological sex: AllType: InterventionalSponsor: Société des Produits Nestlé (SPN)Updated: Dec 26, 2025Locations: 19
Eligibility criteria

Written informed consent has been obtained from at least one parent (or legally... [+9]

History of intolerance to eHF formula [+14]

Read more